Double dose on vaccine news

By ACSH Staff — Sep 20, 2011
We've been saying it for nearly a decade now: Vaccinating infants and schoolchildren against the flu will result in major health benefits. Now the results of a new study led by Dr. John Brownstein of Children's Hospital Boston and published in the Canadian Medical Association Journal provide further evidence that herd immunity (protecting non-immunized populations by increasing overall rates of vaccination) is very effective.

We've been saying it for nearly a decade now: Vaccinating infants and schoolchildren against the flu will result in major health benefits. Now the results of a new study led by Dr. John Brownstein of Children's Hospital Boston and published in the Canadian Medical Association Journal provide further evidence that herd immunity (protecting non-immunized populations by increasing overall rates of vaccination) is very effective.

For women with BRCA mutation, diagnosis comes earlier in the younger generation

By ACSH Staff — Sep 19, 2011
In a new study comparing the difference in the age at breast cancer diagnosis between older and younger generations of women with the BRCA1 and BRCA2 breast cancer gene mutations, researchers from the University of Texas MD Anderson Cancer Center found that breast cancer is diagnosed about eight years earlier in the younger women.

In a new study comparing the difference in the age at breast cancer diagnosis between older and younger generations of women with the BRCA1 and BRCA2 breast cancer gene mutations, researchers from the University of Texas MD Anderson Cancer Center found that breast cancer is diagnosed about eight years earlier in the younger women.

Soy disappointing: Supplements don t prevent post-menopausal artery-hardening

By ACSH Staff — Sep 19, 2011
The case for soy as a cure-all continues to be called into question. In August, we looked at a study that found no link between soy supplements and decreased menopausal symptoms. Now, a study published in Stroke has found that taking soy supplements did nothing to decrease hardening of the arteries in otherwise healthy post-menopausal women.

The case for soy as a cure-all continues to be called into question. In August, we looked at a study that found no link between soy supplements and decreased menopausal symptoms. Now, a study published in Stroke has found that taking soy supplements did nothing to decrease hardening of the arteries in otherwise healthy post-menopausal women.

Little white lies in stroke research?

By ACSH Staff — Sep 19, 2011
Does the proverbial apple a day really prevent stroke, as a Dutch study now in the journal Stroke suggests? Or is it just that the kind of people who eat more fruits and vegetables are more likely to lead healthier lifestyles in general? Who knows?

Does the proverbial apple a day really prevent stroke, as a Dutch study now in the journal Stroke suggests? Or is it just that the kind of people who eat more fruits and vegetables are more likely to lead healthier lifestyles in general? Who knows?

Possible problems with Zofran could be bad news for chemo patients

By ACSH Staff — Sep 19, 2011
Nausea and vomiting, possibly the most unpleasant side effects of chemotherapy, have been treated for the past twenty years with a drug called ondansetron (Zofran). Now, though, the FDA has issued a warning that the drug may lead to dangerous heart arrythmias called prolonged QT intervals a disconcerting prospect for the cancer patients who rely on the drug to quell their chemo-induced nausea. As ACSH s Dr. Josh Bloom notes, Zofran revolutionized the field of chemotherapy.

Nausea and vomiting, possibly the most unpleasant side effects of chemotherapy, have been treated for the past twenty years with a drug called ondansetron (Zofran). Now, though, the FDA has issued a warning that the drug may lead to dangerous heart arrythmias called prolonged QT intervals a disconcerting prospect for the cancer patients who rely on the drug to quell their chemo-induced nausea. As ACSH s Dr. Josh Bloom notes, Zofran revolutionized the field of chemotherapy.

Dr. Oz compromises his medical ethics to promote his arsenic quackery

By ACSH Staff — Sep 16, 2011
As we reported in yesterday's Dispatch, TV's Dr. Oz has been under fire for his season-opening publicity stunt, in which he claimed that the arsenic levels found in apple juice may be cause for concern. Almost immediately, however, the FDA came out against Dr.

As we reported in yesterday's Dispatch, TV's Dr. Oz has been under fire for his season-opening publicity stunt, in which he claimed that the arsenic levels found in apple juice may be cause for concern. Almost immediately, however, the FDA came out against Dr.

Russian federation initiates cold war against smokeless tobacco

By ACSH Staff — Sep 16, 2011
Unfortunately, not all the news is good news: A recently proposed measure in the Russian Federation, much to our (and all others devoted to reducing the toll of smoking) chagrin, aims to ban the manufacture, sale, and importation of smokeless tobacco products.

Unfortunately, not all the news is good news: A recently proposed measure in the Russian Federation, much to our (and all others devoted to reducing the toll of smoking) chagrin, aims to ban the manufacture, sale, and importation of smokeless tobacco products.

Women and the wild west lead the nation in decreasing lung cancer rates

By ACSH Staff — Sep 16, 2011
As the nation works to curb smoking, the Centers for Disease Control and Prevention (CDC) presented some statistics on lung cancer rates that serve as inspiration for all who work in the trenches of public health: National lung cancer rates have declined, particularly among women, who witnessed a 2 percent decrease between 2006 and 2008. That decline in lung cancer incidence was even greater in the West, which experienced a 4 percent decline.

As the nation works to curb smoking, the Centers for Disease Control and Prevention (CDC) presented some statistics on lung cancer rates that serve as inspiration for all who work in the trenches of public health: National lung cancer rates have declined, particularly among women, who witnessed a 2 percent decrease between 2006 and 2008. That decline in lung cancer incidence was even greater in the West, which experienced a 4 percent decline.

Smoking rates continue to decline in the Empire State

By ACSH Staff — Sep 16, 2011
More good news on the anti-smoking front strikes closer to home, as the latest statistics reveal that adult smoking rates in New York fell to a record low of just 14 percent in 2010, compared to 22 percent in 2002. The declining trend was also present among high school students, since only 7 percent were smokers last year as opposed to 18 percent in 2001.

More good news on the anti-smoking front strikes closer to home, as the latest statistics reveal that adult smoking rates in New York fell to a record low of just 14 percent in 2010, compared to 22 percent in 2002. The declining trend was also present among high school students, since only 7 percent were smokers last year as opposed to 18 percent in 2001.